The novel approach of this peptide represents a significant development in the management of type 2 diabetes. Distinct from existing medications, tirzepatide affects dual pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide499527.newsbloger.com/42638017/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment